Cocrystal Pharma, Inc.
COCP
$1.24
$0.065.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 330.00K | 225.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 330.00K | 225.00K | -- | -- | -- |
| Cost of Revenue | 6.09M | 5.07M | 5.06M | 5.47M | 7.76M |
| Gross Profit | -5.76M | -4.84M | -5.06M | -5.47M | -7.76M |
| SG&A Expenses | 4.35M | 4.19M | 3.96M | 4.30M | 4.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.44M | 9.26M | 9.02M | 9.77M | 12.72M |
| Operating Income | -10.11M | -9.03M | -9.02M | -9.77M | -12.72M |
| Income Before Tax | -9.94M | -8.83M | -8.83M | -9.67M | -12.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.94 | -8.83 | -8.83 | -9.67 | -12.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.94M | -8.83M | -8.83M | -9.67M | -12.56M |
| EBIT | -10.11M | -9.03M | -9.02M | -9.77M | -12.72M |
| EBITDA | -10.06M | -8.98M | -8.95M | -9.68M | -12.62M |
| EPS Basic | -0.76 | -0.73 | -0.79 | -0.94 | -1.23 |
| Normalized Basic EPS | -0.47 | -0.46 | -0.49 | -0.58 | -0.77 |
| EPS Diluted | -0.76 | -0.73 | -0.79 | -0.94 | -1.23 |
| Normalized Diluted EPS | -0.47 | -0.46 | -0.49 | -0.58 | -0.77 |
| Average Basic Shares Outstanding | 52.38M | 48.76M | 45.15M | 41.51M | 40.70M |
| Average Diluted Shares Outstanding | 52.38M | 48.76M | 45.15M | 41.51M | 40.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |